TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $58,159,012 | -3.4% | 3,759,498 | -1.9% | 0.07% | +5.8% |
| Q2 2023 | $60,181,090 | -6.6% | 3,830,755 | -2.0% | 0.07% | -10.4% |
| Q1 2023 | $64,416,339 | +7.6% | 3,908,735 | +1.9% | 0.08% | +8.5% |
| Q4 2022 | $59,841,054 | +15.5% | 3,835,990 | -4.0% | 0.07% | +10.9% |
| Q3 2022 | $51,803,000 | -9.3% | 3,994,044 | -1.8% | 0.06% | 0.0% |
| Q2 2022 | $57,115,000 | -5.5% | 4,067,990 | -3.6% | 0.06% | +39.1% |
| Q1 2022 | $60,451,000 | +18.5% | 4,221,381 | +12.8% | 0.05% | +7.0% |
| Q4 2021 | $51,018,000 | -33.7% | 3,743,125 | -20.3% | 0.04% | -34.8% |
| Q3 2021 | $76,938,000 | -3.6% | 4,697,123 | -0.9% | 0.07% | 0.0% |
| Q2 2021 | $79,786,000 | +1.6% | 4,740,712 | +10.2% | 0.07% | -40.5% |
| Q1 2021 | $78,541,000 | +1.2% | 4,301,275 | +0.9% | 0.11% | -1.8% |
| Q4 2020 | $77,619,000 | +9.5% | 4,264,775 | +7.3% | 0.11% | -5.8% |
| Q3 2020 | $70,909,000 | -5.7% | 3,974,738 | -5.3% | 0.12% | -7.7% |
| Q2 2020 | $75,218,000 | -1.7% | 4,195,081 | -16.8% | 0.13% | -17.2% |
| Q1 2020 | $76,504,000 | -24.1% | 5,039,797 | -1.4% | 0.16% | +9.0% |
| Q4 2019 | $100,809,000 | +10.6% | 5,109,419 | -3.6% | 0.14% | -5.9% |
| Q3 2019 | $91,171,000 | -68.8% | 5,300,636 | -67.9% | 0.15% | -7.8% |
| Q2 2019 | $292,374,000 | +200.2% | 16,518,309 | +245.5% | 0.17% | 0.0% |
| Q1 2019 | $97,395,000 | – | 4,781,268 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |